Effect of saffron on liver metastases in patients suffering from cancers with liver metastases: A randomized, double blind, placebo-controlled clinical trial | ||
| Avicenna Journal of Phytomedicine | ||
| مقاله 8، دوره 5، شماره 5، آذر و دی 2015، صفحه 434-440 اصل مقاله (481.24 K) | ||
| نوع مقاله: Original Research Article | ||
| شناسه دیجیتال (DOI): 10.22038/ajp.2015.4667 | ||
| نویسندگان | ||
| Azar Hosseini1؛ Seyed Hamed Mousavi2؛ Anis Ghanbari2؛ Fatemeh Homaei-Shandiz3؛ Hamid-Reza Raziee3؛ Masoud Pezeshki-Rad4؛ Seyed Hadi Mousavi* 5 | ||
| 1Pharmacological Research Center of Medicinal Plants, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. | ||
| 2Department of Pharmacology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. | ||
| 3Department of Oncology, Omid Hospitsal, Mashhad, Iran. | ||
| 4Department of Oncology, Emam Reza Hospitsal, Mashhad, Iran. | ||
| 5Medical Toxicology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. | ||
| چکیده | ||
| Objective: Cancer represents the second cause of mortality in the world. Saffron as a medicinal plant is known for its anti-cancer and anti-depressant properties. In this randomized double blind clinical trial, the effects of saffron on response to treatment in patients suffering from liver metastasis were evaluated. Materials and Methods: Thirteen patients suffering from liver metastases who referred to Ghaem and Imam Reza hospital, Mashhad, Iran were included in this study and then divided into two different groups. Both groups received chemotherapy regimen. Patients in group one were treated with saffron capsule (50 mg, twice daily) during chemotherapy periods whereas patients in group two received placebo. A sum of the longest diameter were calculated and compared for all lesions in IV contrast CT scan before and after the treatment. Results: from 13 patients included in this study, six patients quit and seven continued until the end. In saffron-treated group, two patients showed partial and complete response (50%) whereas in placebo group, no response was seen. Also, two deaths in placebo and one in saffron group occurred. Conclusion: This research suggests that saffron might be useful in patients suffering from liver metastasis. However, further investigations with larger sample size are required. | ||
| کلیدواژهها | ||
| Saffron؛ Cancer؛ Liver Metastases | ||
| مراجع | ||
|
Abdullaev FI, Frenkel GD. 1992. The Effect of Saffron on Intracellular DNA, RNA and Protein Synthesis in Malignant and Non-malignant Human Cells. Biofactors, 4: 43–5.
Abdullaev JF, Espinosa-Aguirre JJ .2004. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detection Prev, 28: 430–436.
Aung HH, Wang CZ, Ni M. 2007. Crocin from Crocus sativus Processes Significant Anti-proliferation Effects on Human Colorectal Cancer Cells. Exp Oncol, 29: 175–180.
Bamshad Z, Safikhani F. 2006. Assessment of mental health of women with breast cancer. Abstract Book of National congress of care in special diseases. Ahvaz; Ahvaz University of Medical Sciences. p.56.
Basker D, Negbi M. 1983. The use of saffron. Econ Bot, 37: 228–236.
Biswal BM, Sulaiman SA, Ismail HC, Zakaria H, Musa KI. 2013. Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients. Integr Cancer Ther, 12: 312-22.
Carmona M, Zalacain A, Salinas MR, Alonso GL. 2007. A new approach to saffron aroma. Crit Rev Food Sci Nutr, 47: 145–159.
Choan E, Segal R, Jonker D, Malone S, Reaume N, Eapen L, Gallant V.2005. A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach. Urol Oncol, 23: 108-13.
Chryssanthi DG, Dedes PG, Karamanos NK, Cordopatis P, Lamari FN. 2011. Crocetin inhibits invasiveness of MDA-MB-231 breast cancer cells via downregulation of matrix metalloproteinases. Planta Medica, 77: 146–151.
Chryssanthi DG, Lamari FN, Iatrou G, Pylara A, Karamanos NK, Cordopatis P. 2007. Inhibition of Breast Cancer Cell Proliferation by Style Constituents of Different Crocus Species. Anticancer Res, 27: 357–62.
D’Alessandro AM, Mancini A, Lizzi AR. 2013. Crocus sativus stigma extract and its major constituent crocin possess significant antiproliferative properties against human prostate cancer. Nutr Cancer, 65: 930–942.
Dalkic E, Wang X, Neil W, Chan Christina. 2010. Cancer-Drug Associations: A Complex System. PLoS ONE, 5: e100315.
Daly ES. 1998. Protective effect of cysteine and vitamine E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rat. J Pharm Belg, 53:87-93.
Das I, Das S, Saha T. 2010. Saffron suppresses oxidative stress in DMBA-induced skin carcinoma: A histopathological stud. Acta Histochem;112: 317-27.
Davis CD. 2007. Nutritional interactions: credentialing of molecular targets for cancer prevention. Exper Biol Med, 232: 176–183.
Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB and Abbruzzese JL. 2008. Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer. Clinical Cancer Res, 14: 4491-4499.
Firdous AP, Sindhu ER, Ramnath V, Kuttan R. 2010. Anti-mutagenic and anti-carcinogenic potential of the carotenoid meso-zeaxanthin. Asian Pac J Cancer Prev, 11: 1795–1800.
Garc´ıa-L´opez E, Gonz´alez-Gallardo A, Antarami´an A. 2012. In vitro conversion of 𝛽-carotene to retinal in bovine rumen fluid by a recombinant 𝛽-carotene- 15, 15 mooxygenase. Int J Vitam Nutr Res, 82: 94–103.
García-Olmo DC1, Riese HH, Escribano J, Ontañón J, Fernandez JA, Atiénzar M, García-Olmo D. 1999. Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L.): an experimental study in the rat. Nutr Cancer, 35 :120-126.
Hosseinzadeh H, Sadeghnia HR. 2007. Effect of Safranal, A Constituent of Crocus sativus (Saffron), on Methyl Methanesulfonate (MMS)-Induced DNA Damage in Mouse Organs: An Alkaline Single-Cell Gel Electrophoresis (Comet) Assay. DNA Cell Biol, 26: 841-6.
Hsu B. 1980. The use of herbs as anticancer agents. Am J Chinese Med, 8: 301-306.
Jnaneshwari S1, Hemshekhar M, Santhosh MS, Sunitha K, Thushara R, Thirunavukkarasu C, Kemparaju K, Girish KS. 2013. Crocin, a dietary colorant, mitigates cyclophosphamide-induced organ toxicity by modulating antioxidant status and inflammatory cytokines. J Pharm Pharmacol, 65: 604-614.
Johnstone RW, Ruefli AA, Lowe SW. 2002. Apoptosis: a link between cancer genetics and chemotherapy. Cell, 108: 153–164.
Konoshima T, Takasaki M, Tokuda. 1998. Crocin and Crocetin Derivatives Inhibit Skin Tumour Promotion in Mice. Phytother Res,12: 400–404.
Lamson DW, Brignall MS. 1999. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Alter Med Rev, 4: 304–329.
Liu FS. 2009. Mechanisms of chemotherapeutic drug resistance in cancer therapy-a quick review. Taiwan J Obstet Gyne, 48: 239–244.
Loprinzi CL, Barton DL, Jatoi A. 2007. Symptom control trials: a 20-year experience. J Support Oncol, 5: 119–128.
Magesh V, Singh JP, Selvendiran K, Ekambaram G, Sakthisekaran D. 2006. Antitumour Activity of Crocetin in Accordance to Tumor Incidence, Antioxidant Status, Drug Metabolizing Enzymes and Histopathological Studies. Mol Cell Biochem, 287: 127–35.
Martin G, Goh E, Neff AW.2002. Evaluation of the developmental toxicity of crocetin on Xenopus. Food Chem Toxicol, 40: 959-964.
Moln´ar J, Kars MD, Gunduz U. 2009. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp. Acta Histochemica, 111: 329–333.
Mousavi SH, Moallem SA, Mehri S, Shahsavand S, Nassirli H, Malaekeh-Nikouei B. 2011. Improvement of cytotoxic and apoptogenic properties of crocin in cancer cell lines by its nanoliposomal form. Pharm Biol, 49: 1039-1045.
Mousavi SH, Tavakkol-Afshari J, Brook A, Anarkooli Jafari I. 2009. Role of caspases and Bax protein in saffron-induced apoptosis in MCF-7 cells. Food Chem Toxicol, 47: 1909–1913.
Nair SC, Pannikar B, Panikkar KR. 1991. Antitumour activity of saffron (Crocus sativus). Cancer Lett, 57: 109–114.
Nair SC.1991. Antitumor activity of saffron (Crocus sativus). Cancer Lett. 57: 109-114.
Nguyen AV, Martinez M, Stamos MJ, Moyer MP, Planutis K, Hope C, Holcombe RF. 2009. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manage Res, 1: 25–37.
Prasad KN, Cole WC, Kumar B, Prasad KC. 2001. Scientific rationale for using high-dose multiple micronutrients as an adjunct to standard and experimental cancer therapies. J Am Coll Nutr, 20: 450S–463S.
Premkumar K, Abraham SK, Santhiya ST, Ramesh A. 2003. Protective effects of saffron( Crocus sativus Linn.) on genotoxins-induced oxidative stress in Swiss albino mice, Phytother Res, 17: 614–617.
Salomi MJ, Nair SC, Panikkar KR. 1991. Inhibitory Effects of Nigella sativa and Saffron (Crocus sativus) on Chemical Carcinogenesis in Mice. Nutr Cancer,16: 67–82.
Schmidt M, Betti G, Hensel A. 2007. Saffron in Phytotherapy: Pharmacology and Clinical Uses. Wien Med Wochenschr, 157:315-319.
Surh Y, Na H, Lee HJ. 2004. Chemopreventive Effects of Selected Spice Ingredients. Phytopharmaceuticals in Cancer Chemoprevention. pp. 575–598. CRC Press.
Tanaka T, Shnimizu M. 2012. Cancer chemoprevention by carotenoids. Molecules, 17: 3202–3242.
Tavakkol-Afshari J, Brook A, Mousavi SH. 2008. Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food Chem Toxicol 46: 3443–3447.
Zhou H, Zou P, Chen ZC, You Y. 2007. A novel vicious cycle cascade in tumor chemotherapy. Med Hypotheses, 69: 1230–1233. | ||
|
آمار تعداد مشاهده مقاله: 28,097 تعداد دریافت فایل اصل مقاله: 5,164 |
||